TRiCares
Pre-clinicalTricuspid regurgitation (TR) is a serious cardiac condition that occurs when the tricuspid valve, which regulates blood flow between the right atrium and the right ventricle, fails to close properly, causing blood to flow back into the right atrium.
Founded
2015
Focus
Medical DevicesCardiovascular
About
Tricuspid regurgitation (TR) is a serious cardiac condition that occurs when the tricuspid valve, which regulates blood flow between the right atrium and the right ventricle, fails to close properly, causing blood to flow back into the right atrium.
Funding History
2Total raised: $45M
Series B$30MAndera PartnersSep 15, 2021
Series A$15MEarlybird Venture CapitalMay 15, 2019
Company Info
TypePrivate
Founded2015
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile